Exome sequencing of senescence-accelerated mice (SAM) reveals deleterious mutations in degenerative disease-causing genes by Kumpei Tanisawa et al.
Tanisawa et al. BMC Genomics 2013, 14:248
http://www.biomedcentral.com/1471-2164/14/248RESEARCH ARTICLE Open AccessExome sequencing of senescence-accelerated
mice (SAM) reveals deleterious mutations in
degenerative disease-causing genes
Kumpei Tanisawa1,2, Eri Mikami1,2,3, Noriyuki Fuku1, Yoko Honda1, Shuji Honda1, Ikuro Ohsawa4, Masafumi Ito5,
Shogo Endo6, Kunio Ihara7, Kinji Ohno8, Yuki Kishimoto9, Akihito Ishigami9, Naoki Maruyama9, Motoji Sawabe10,
Hiroyoshi Iseki11, Yasushi Okazaki11, Sanae Hasegawa-Ishii12, Shiro Takei12, Atsuyoshi Shimada12,
Masanori Hosokawa12, Masayuki Mori13, Keiichi Higuchi13, Toshio Takeda14, Mitsuru Higuchi15 and Masashi Tanaka1*Abstract
Background: Senescence-accelerated mice (SAM) are a series of mouse strains originally derived from unexpected
crosses between AKR/J and unknown mice, from which phenotypically distinct senescence-prone (SAMP) and -resistant
(SAMR) inbred strains were subsequently established. Although SAMP strains have been widely used for aging research
focusing on their short life spans and various age-related phenotypes, such as immune dysfunction, osteoporosis, and
brain atrophy, the responsible gene mutations have not yet been fully elucidated.
Results: To identify mutations specific to SAMP strains, we performed whole exome sequencing of 6 SAMP and 3
SAMR strains. This analysis revealed 32,019 to 38,925 single-nucleotide variants in the coding region of each SAM strain.
We detected Ogg1 p.R304W and Mbd4 p.D129N deleterious mutations in all 6 of the SAMP strains but not in the SAMR
or AKR/J strains. Moreover, we extracted 31 SAMP-specific novel deleterious mutations. In all SAMP strains except
SAMP8, we detected a p.R473W missense mutation in the Ldb3 gene, which has been associated with myofibrillar
myopathy. In 3 SAMP strains (SAMP3, SAMP10, and SAMP11), we identified a p.R167C missense mutation in the Prx
gene, in which mutations causing hereditary motor and sensory neuropathy (Dejerine-Sottas syndrome) have been
identified. In SAMP6 we detected a p.S540fs frame-shift mutation in the Il4ra gene, a mutation potentially causative of
ulcerative colitis and osteoporosis.
Conclusions: Our data indicate that different combinations of mutations in disease-causing genes may be responsible
for the various phenotypes of SAMP strains.
Keywords: Exome sequencing, Senescence-accelerated mice, AgingBackground
Aging is one of the most complex biological processes that
are regulated by both genetic and environmental factors,
but its molecular basis remains largely unknown [1].
Senescence-accelerated mice (SAM) are a series of inbred
strains developed from the AKR/J strain, consisting of 9
senescence-prone strains (SAMP) and 4 senescence-
resistant strains (SAMR) [2,3]. Compared with SAMR* Correspondence: mtanaka@tmig.or.jp
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reproduction in any medium, provided the oraccelerated-senescence phenotypes such as a short life
span and early onset of various age-related pathological
changes [4]. These SAM strains have therefore been used
as a model to elucidate the mechanism of aging.
It has remained unknown why SAM strains exhibit dif-
ferent phenotypes, even though they were derived from a
common ancestor [2,3]. Genetic analyses by use of bio-
chemical and immunological markers and endogenous
murine leukemia virus (MuLV) proviral markers revealed
that each SAM strain constitutes a genetically distinct
group. Comparisons of the SAM strains with their paren-
tal AKR/J strain indicated significant differences in genetic
background between them, corroborating the hypothesisal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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probability of accidental outbreeding of the AKR/J strain
in the course of the development of SAM [5,6].
Despite intense characterization of SAM strains, the
genes responsible for accelerated senescence and patho-
logic changes in SAMP strains remain unidentified ex-
cept for mutations in the Apoa2, Sfrp4, and Fgf1 genes
[7-9]. Xia et al. performed genotyping for 581 microsat-
ellite markers in 13 established SAM strains, and identi-
fied 4 loci that were different between the SAMP and
SAMR strains [10], although the responsible genes re-
main unknown. Furthermore, genetic analysis of crosses
between the SAMP1 and SAMR1 strains also suggested
that combinations of multiple gene mutations are re-
sponsible for the phenotypes [11].
Recent advances in next-generation sequencing tech-
nologies have made it possible to rapidly determine the
DNA sequence of the whole genome of individual humans
[12,13]. As an alternative approach to whole-genome se-
quencing, whole-exome sequencing is an efficient strategy
with regard to reducing the cost and workload [14,15].
Exome sequencing enables us to obtain information on
functionally important coding regions. Although this type
of sequencing is useful for identification of the cause of
Mendelian disorders [16,17], it is difficult to explore genes
responsible for complex traits by using this approach. The
difficulty in identification of combined effects of various
variants in humans is mainly ascribable to the presence of
heterozygosity as well as homozygosity in humans [18]. In
contrast, inbred mouse strains such as SAM strains are
useful models to analyze the combined effects of genes be-
cause we can focus on homozygous variations only.
In the present study, we performed whole exome se-
quencing of 6 SAMP and 3 SAMR strains to identify the
single-nucleotide variations (SNVs) in their entire exomes.
We hypothesized that the accelerated-senescence pheno-
types and short life span observed in SAMP strains are
caused by coding-region mutations that are present specif-
ically in SAMP strains but are absent in the SAMR strains.
We obtained a full view of the exome signature of SAM
strains and report herein several mutations that potentially
cause various pathogenic phenotypes. Our data demon-
strate that this innovative approach, whole-exome sequen-
cing, is paving the way to the unraveling of the genetic
mechanisms of accelerated senescence and pathogenic
phenotypes in mouse models.
Results
Whole-exome sequencing revealed exonic profiles of SAM
strains
Whole-exome capture and next-generation sequencing
were successfully performed on 11 mouse strains, i.e.,
SAMP1/SkuSlc, SAMP3/SlcIdr, SAMP6/TaSlc, SAMP8/
TaSlc, SAMP10/TaSlc, SAMP11/SlcIdr, SAMR1/SlcIdr,SAMR1/TaSlc, SAMR3B/SlcIdr, AKR/J, and C57BL/6J
strains, and generated on average 73 million, single-end
50-bp reads per sample (Table 1). The number of aligned
reads was about 51 million including 1.7 gigabases of se-
quence per sample, and the generated sequences
achieved a mean read depth of 33.1 ± 11.8×. On average,
91.8 ± 0.4% of the target base pairs were covered by at
least one read; and 72.9 ± 6.5% of the target base pairs
were covered by at least 10 reads. After removal of low-
quality reads, duplicates, and reads mapped out of
targeted regions, SNV detection was performed by use
of Avadis NGS ver1.3. The whole-exome sequencing
identified 85,198 to 112,245 SNVs for SAMP strains,
108,059 to 121,517 for SAMR strains, 100,463 for AKR/J,
and 3,484 for C57BL/6J on targeted regions from the ref-
erence mouse genome sequence GRCm38 (NCBI37/mm9;
Table 2). The number of SNVs in C57BL/6J mice was
much lower than that of those in the other strains, be-
cause the genome sequence of C57BL/6J was used as the
reference for the mouse genome. These 3,484 SNVs in the
C57BL/6J strain may be attributed to individual variability
rather than to sequencing error. Actually, several studies
reported that minor genetic and phenotypic variations
could be observed even among individual C57BL/6J mice
[19,20]. Although the targeted regions included non-
coding regions, we restricted our analysis to exonic SNVs
of 32,019 to 35,817 variants for SAMP strains, 36,174 to
38,925 for SAMR strains, 32,816 for AKR/J, and 1,407 for
the C57BL/6J strain. Exonic SNVs included 6,507 to 7,843
non-synonymous SNVs for each sample except for
C57BL/6J. Moreover, 230 to 491 novel non-synonymous
SNVs were detected after comparison with the public
database dbSNP128 and genome sequences of 17 inbred
strains of laboratory mice [21]. In the same way, novel
multiple nucleotide variants (MNV), frame-shift muta-
tions, and nonsense mutations were detected in each
strain (Table 2). We calculated the rates of false positive
and false negative by validating 32 known and 61 novel
SNVs by using the Sanger method (Additional file 1:
Tables S1-S3). Although the false-positive rate was 14% for
novel SNVs, the entire false-positive rate was 8.0%, indi-
cating that high-quality calls for homozygous SNVs
were gained.
No novel exonic mutations commonly detected among
SAMP strains
Surprisingly, we detected no novel mutations that were
present in all of the SAMP strains, but absent in the other
strains (Additional file 1: Table S4). When including the
SNVs previously reported in other strains, 7 SNVs (Ogg1
p.R304W, Tsen2 p.228L, Mbd4 p.D129N, D6Wsu116e p.
P556S, Alox5 p.V95I, Moxd1 p.R516K, and Moxd1 p.
K583N) were commonly detectable in all of the SAMP
strains but absent in SAMR, AKR/J and C57BL/6J strains




















Targeted exons 221,784 221,784 221,784 221,784 221,784 221,784 221,784 221,784 221,784 221,784 221,784 221,784
Target exons with no coverage 7,740 7,132 6,945 7,004 7,238 6,867 6,924 6,332 7,165 7,557 7,384 7,117
Total Target bases 51,555,503 51,555,503 51,555,503 51,555,503 51,555,503 51,555,503 51,555,503 51,555,503 51,555,503 51,555,503 51,555,503 51,555,503
Target bases not covered 4,530,669 4,368,898 4,182,707 4,142,933 4,167,472 3,987,407 4,013,747 3,824,098 4,138,242 4,334,915 4,556,739 4,204,348
Percent of target bases not covered 8.8% 8.5% 8.1% 8.0% 8.1% 7.7% 7.8% 7.4% 8.0% 8.4% 8.8% 8.2%
Total reads 51,745,673 35,778,184 46,935,236 49,808,616 46,543,914 60,395,876 55,759,506 92,605,357 59,459,968 33,681,727 33,076,734 51,435,526
Reads in target regions 37,488,887 30,022,764 38,828,147 39,487,865 35,776,159 44,391,567 43,666,102 76,028,527 42,978,757 23,655,073 24,442,946 39,706,072
Reads off target regions 14,256,786 5,755,420 8,107,089 10,320,751 10,767,755 16,004,309 12,093,404 16,576,830 16,481,211 10,026,654 8,633,788 11,729,454
Percent of reads in target regions 72.4% 83.9% 82.7% 79.3% 76.9% 73.5% 78.3% 82.1% 72.3% 70.2% 73.9% 76.9%
Coverage at 1× 91.2% 91.5% 91.9% 92.0% 91.9% 92.3% 92.2% 92.6% 92.0% 91.6% 91.2% 91.8%
Coverage at 5× 83.0% 81.6% 84.4% 85.2% 84.8% 86.6% 86.5% 89.0% 86.3% 80.5% 79.9% 84.4%
Coverage at 10× 71.4% 67.1% 73.2% 74.6% 73.4% 77.6% 77.4% 84.0% 77.4% 63.1% 62.9% 72.9%
Coverage at 20× 49.6% 41.6% 50.9% 52.9% 50.0% 57.6% 57.2% 72.3% 57.6% 34.6% 35.1% 50.9%









































Total SNVs 112245 85198 90734 97039 106341 104290 108059 108880 121527 100463 3484
Exonic SNVs 35791 32019 32659 34048 35752 35817 36174 38432 38925 32816 1407
Homozygous 28916 26142 27914 26142 29282 29310 30253 25891 31338 26880 158
Non-synonymous 7364 6811 7106 7435 7429 7413 7588 6507 7843 6903 63
Novel 310 260 316 273 317 286 317 230 491 245 39
Total MNVs 2251 1610 1757 1870 2093 2007 2207 2210 2245 1834 67
Exonic MNVs 529 433 478 473 528 511 535 571 539 407 22
Homozygous 404 346 375 393 428 412 406 420 417 349 14
Non-synonymous 258 228 243 260 279 273 262 274 294 215 12
Novel 49 33 48 43 50 48 51 63 32 32 8
Total Indels 4439 3189 3653 3932 4446 4286 4749 4287 4943 3988 111
Exonic Indels 470 371 406 413 478 494 505 498 554 411 33
Homozygous 83 64 65 62 69 68 81 77 94 76 3
Frameshift 11 8 8 9 7 8 10 10 14 8 0
Novel 3 2 4 6 2 3 4 3 7 2 0
Total Gain of Stops 242 125 149 155 158 153 177 246 253 132 30
Homozygous 72 56 68 76 61 67 73 57 68 60 1
Novel 10 2 4 6 8 5 10 8 5 1 1
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function, we predicted Ogg1 p.R304W to be deleterious by
both SIFT and PolyPhen-2 programs (SIFT score: 0.00,
PolyPhen-2 score: 0.999), and Mbd4 p.D129N to be dele-
terious only by the PolyPhen-2 program (SIFT score: 0.12,
PolyPhen-2 score: 0.996). We performed functional en-
richment analysis to confirm whether common features
could be detected among these 6 genes. GO analysis
showed that “base-excision repair” (Ogg1 and Mbd4) was
most significantly overrepresented (adjusted p-valueTable 3 Missense SNVs detected among all of the SAMP strai
Location Gene symbol Gene name Nucleo
chan
Chr6:113283636 Ogg1 8-oxoguanine DNA-glycosylase 1 c.1125
Chr6:115509985 Tsen2 tRNA splicing endonuclease 2
homolog (S. cerevisiae)
c.728C





DNA segment, Chr 6, Wayne
State University 116, expressed
(WASH complex subunit FAM21)
c.1737
Chr6:116360826 Alox5 arachidonate 5-lipoxygenase c.2040
Chr10:24020000 Moxd1 monooxygenase, DBH-like 1 c.1634
Chr10:24021342 Moxd1 monooxygenase, DBH-like 1 c.1836
*Human protein sequence is in conflict with the mouse sequence at the position in=0.0003; Table 4). Ogg1 and Mbd4 genes were included
among the entire top 5 of overrepresented GO categories.
Only “response to stress” included Alox5 in addition to
Ogg1 and Mbd4 (adjusted p-value=0.0202). We also
checked whether these 6 genes had been reported to be
associated with the aging process by referring to the
GenAge database [22], but no such genes were recorded
in the database (data not shown).
The Ogg1 p.R304W mutation was previously observed









SNV carriers in 17 inbred
strains of laboratory mice
C>T p.R304W 0 0.999 NOD/ShLtJ
>T p.P228L 0.32 0* 129P2/OlaHsd, 129S1/SvImJ,
129S5SvEvBrd, DBA/2J, LP/J,
NOD/ShiLtJ, NZO/HlLtJ, WSB/EiJ
>T p.D129N 0.12 0.996 129P2/OlaHsd, 129S1/SvImJ,
129S5SvEvBrd, DBA/2J, LP/J,
NOD/ShiLtJ, NZO/HlLtJ
C>T p.P556S 0.73 0.059* 129P2/OlaHsd, 129S1/SvImJ,
129S5SvEvBrd, DBA/2J, LP/J,
NOD/ShiLtJ, NZO/HlLtJ
C>T p.V646I 0.07 0 129P2/OlaHsd, 129S1/SvImJ,
129S5SvEvBrd, DBA/2J, LP/J,
NOD/ShiLtJ, NZO/HlLtJ
G>A p.R516K 1 0* NOD/ShiLtJ, WSB/EiJ
A>C p.K583N 0.39 0.006 NOD/ShiLtJ, WSB/EiJ
dicated.
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strains [23]. The Ogg1 gene encodes the enzyme 8-
oxoguanine DNA glycosylase, by which oxidatively modi-
fied bases are repaired [24,25]. The methyl-CpG-binding
domain protein, encoded by the Mbd4 gene, is also a
DNA repair enzyme that is responsible for removing
mismatched thymine or uracil within methylated CpG
sites [26]. Similar to Ogg1 p.R304W, Mbd4 p.D129N was
previously found in normal mice strains including 129P2/
OlaHsd, 129S1/SvImJ, 129S5SvEvBrd, DBA/2J, LP/J,
NOD/ShiLtJ, and NZO/HlLtJ [21]. It is interesting that all
of the SAMP strains as well as the NOD/ShiLtJ strain
share these genes that are involved in DNA repair, i.e.,
Ogg1 and Mbd4. NOD/ShiLtJ is a mouse model of type 1
diabetes, showing a short life span [27,28]. Nevertheless,
we should be careful to conclude that the combination of
these mutations regulates the accelerated-senescence
phenotype of SAMP, because the short life span of NOD/
ShiLtJ is generally attributed to diabetes caused
by insulitis.
Unique deleterious mutations identified in each substrain
We hypothesized that different disease phenotypes among
SAMP strains are caused by deleterious SNVs that are
unique to each strain or a subgroup of strains. We focused
on novel non-synonymous SNVs specific to each strain.
We extracted SAMP-specific novel non-synonymous
SNVs, after excluding mutations in olfactory-receptor and
vomeronasal-receptor superfamily genes or in pseudogenes.
In addition to nonsense and frameshift mutations, we fo-
cused on dysfunctional mutations predicted to be deleteri-
ous by SIFT or PolyPhen-2 programs. As the results, we
detected 44 deleterious mutations. Subsequently, 31 of
these deleterious mutations were validated by Sanger se-
quencing (Tables 5,6 and 7, Additional file 1: Tables S5-S9).
Among these 31 mutations, only 7 of them were shared by
multiple strains (Table 5), whereas the other 24 mutations
were detected in only a single strain. Functional enrichment
analysis for the genes including these 31 mutations showedTable 4 Top 5 overrepresented GO terms within the 6 genes
strains, but absent in the SAMR and AKR/J strains
GO ID GO category Number of
reference genes
in the category
Number of genes in





GO:0006281 DNA repair 213 2





GO:0006974 response to DNA
damage stimulus
274 2that “gap junction channel activity” (Gja1 and Gja3)
was the most significantly overrepresented (p=0.0043;
Additional file 1: Table S10). However, GO category “aging”
and its subcategories were not significantly overrepre-
sented. We also confirmed that no genes including these 31
mutations were recorded in the GenAge database (data not
shown) [22].
We also detected 52 novel deleterious mutations in
SAMR strains (Additional file 1: Table S11). These results
are not surprising, because it has been reported that
SAMR strains exhibit several diseases such as non-thymic
lymphoma, histiocytic sarcoma, and ovarian cysts [29], al-
though the SAMR strains have been used as control
groups against the SAMP strains. Novel deleterious muta-
tions including Fbxl13 p.S734N, Sh3bp5l p.R217W,
Tnrc6a p.A278V, and Zkscan2 p.C232X were detected
among all of the SAMP strains in addition to being found
in several SAMR strains (Additional file 1: Table S12).
These mutations may be associated with susceptibility to
diseases in SAMP strains as well as in SAMR ones.
Prx p.R167C mutation in SAMP3, SAMP10, and SAMP11
strains
Interestingly, we detected deleterious mutations in several
genes that had been earlier reported to be associated with
severe genetic disorders in both humans and mice. For
example, the Prx p.R167C mutation (SIFT score: 0.01,
PolyPhen-2 score: 0.998) was detected in 3 SAMP strains
(SAMP3/SlcIdr, SAMP10/TaSlc, and SAMP11/SlcIder;
Table 5). The Prx gene encodes periaxin, a protein required
for the maintenance of myelin [30]. Because myelin is ne-
cessary for the conduction of high-frequency and high-
velocity nerve impulses by saltatory conduction, its defects
lead to severe neuropathy. In humans, nonsense mutations
in periaxin cause an autosomal recessive form of CMT4F
(Dejerin-Sottas disease), which is one of the severe heredi-
tary motor and sensory neuropathies [31,32]. It was
also reported that periaxin-knockout mice exhibit periph-










0.01 1.35×10-5 0.0003 Mbd4, Ogg1
0.08 0.0022 0.0202 Mbd4, Ogg1
0.39 0.0042 0.0202 Alox5, Mbd4,
Ogg1
0.09 0.0028 0.0202 Mbd4, Ogg1
0.1 0.0036 0.0202 Mbd4, Ogg1
Table 5 Novel deleterious mutations detected among multiple SAMP strains, but absent in the SAMR and AKR/J strains



















Chr7:28301176 Prx periaxin c.784C>T p.R167C SAMP3/SlcIdr, SAMP10/TaSlc,
SAMP11/SlcIdr
0.01 0.998
Chr11:49958661 Tbc1d9b TBC1 domain
family, member 9B
c.560T>C p.S161P SAMP3/SlcIdr, SAMP10/TaSlc 0 0.867
Chr11:70277672 Zmynd15 zinc finger, MYND-
type containing 15
c.1859C>T p.T461M SAMP3/SlcIdr, SAMP10/TaSlc 0.05 N.A.
Chr18:37455608 Pcdhb2 protocadherin
beta 2
c.1115G>A p.G327R SAMP10/TaSlc, SAMP11/SlcIdr 0 N.A.
Chr18:37495244 Pcdhb6 protocadherin
beta 6
c.1563G>T p.E521D SAMP10/TaSlc, SAMP11/SlcIdr 0 N.A.
†Human protein sequence is in conflict with the mouse sequence at the position indicated.
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within the nuclear localization signal (NLS), which is ne-
cessary for this protein to be imported into the nucleus
from the cytoplasm (Figure 1) [34]. Localization of periaxin
in the nucleus is observed in murine embryonic Schwann
cells only for a limited period of time [35]. Because the ar-
ginine at position167 is highly conserved among mamma-
lian species, this mutation in NLS might disturb the
transfer of periaxin into the nucleus, thereby adversely af-
fecting the normal differentiation of Schwann cells.
Ldb3 p.R473W mutation in all of SAMP strains except for
SAMP8
In the Ldb3 gene, encoding LIM domain-binding protein
3, the p.R467W mutation (SIFT score: 0.02, PolyPhen-2
score: 0.968) was detected in all of the SAMP strains ex-
cept for SAMP8/TaSlc (Table 5). Ldb3 is a component of
the sarcomere Z disk protein complex expressed in cardiac
and skeletal muscles, and it is connected to calsarcin-1 and
α-actinin [36]. Mutations in the Ldb3 gene are responsibleTable 6 Novel deleterious mutations specific to SAMP6/TaSlc
Location Gene symbol Gene name
Chr2:29947531 Zdhhc12 zinc finger, DHHC domain containing 12
Chr2:31793494 Lamc3 laminin gamma 3
Chr7:132719753 Il4ra interleukin 4 receptor, alpha
Chr10:79474903 Abca7 ATP-binding cassette, sub-family A
(ABC1), member 7
Chr15:99998371 Dip2b DIP2 disco-interacting protein 2 homolog
Chr17:25257897 Ptx4 pentraxin 4
Chr19:4153338 Coro1b coronin, actin-binding protein 1B
*The score is low confidence because the prediction was based on sequences too cfor myofibrillar myopathy and dilated cardiomyopathy in
humans [37,38]. In addition, LDB3 exon 4 is aberrantly
spliced in myotonic dystrophy type 1 [39]. Pathological
changes in skeletal and cardiac muscles of SAMP strains,
however, have not been fully analyzed.
Gja3 p.S405P mutation in SAMP3, SAMP6, SAMP10, and
SAMP11 strains
We detected the Gja3 p.S405P mutation (SIFT score: 0.09,
PolyPhen-2 score: 0.917) in 4 SAMP strains (SAMP3/
SlcIdr, SAMP6/TaSlc, SAMP10/TaSlc and SAMP11/
SlcIdr; Table 5). Gap junction protein alpha 3, encoded by
Gja3, is specifically expressed in the plasma membrane of
lens fiber cells to form gap junctions [40]. Gap junctions
directly connect the cytoplasm of adjacent cells, and allow
various molecules and ions to pass freely between cells,
functioning for the maintenance of osmotic and metabolic
balance in the avascular lens. A large number of studies
have reported the association of mutations of the GJA3




SIFT score Polyphen-2 score
c.381G>A p.R112C 0 0.999
c.4202A>G p.D1380G 0.05 0.399
c.1860delC p.S540fs N.A. N.A.
c.5477G>A p.R1826H 0.01 0.108
B c.1708G>A p.A544T 0.05 0.17
c.176A>T p.R34S 0* 0.999
c.1253C>T p.R393W 0 0.998
losely related.
Table 7 Novel deleterious mutations specific to SAMP8/TaSlc




SIFT score Polyphen-2 score
Chr2:60190230 Ly75 lymphocyte antigen 75 c.1657G>A p.R553W 0.02 0.997
Chr5:75023400 Lnx1 ligand of numb-protein X 1 c.685T>A p.N154Y 0 0.318
Chr15:34358663 Matn2 matrilin 2 c.2668C>T p.A806V 0.01 0.717
Chr16:14195230 Myh11 myosin, heavy polypeptide 11,
smooth muscle
c.5938C>T p.R1945H 0.17 0.99
Chr16:17506416 Aifm3 apoptosis-inducing factor,
mitochondrion-associated 3
c.1966G>T p.K582N 0.01 0.879
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SAMP6 strain
We next analyzed deleterious SNVs unique to a single
SAMP strain, i.e., not shared with other SAMP strains. We
detected 7 deleterious mutations specific to the SAMP6/
TaSlc strain, which has been used as a mouse model of
osteoporosis or ulcerative colitis [43,44]. Among these
7 mutations, we focused on the Il4ra p.S540fs frameshift
mutation (Figure 2, Table 6). The Il4ra p.S540fs substitution
immediately generates a stop codon at this position. Osteo-
porosis is caused by bone resorption in excess of bone for-
mation. The differentiation of osteoclasts is promoted by
RANKL, a membrane-bound cytokine, as well as by inflam-
matory cytokines such as TNF-α, IL-1 and IL-6 [45-48].
These proteins are mainly expressed in type 1 T-helper
lymphocytes (Th1 cells). IL-4, a Th2 cytokine suppresses
the formation of Th1 cells to keep the proper balance be-
tween Th1/Th2 cytokines. A functional loss of the Il4ra
protein would lead to activation of Th1 cells. Therefore,
both osteoporosis and ulcerative colitis in SAMP6 might be
explained by activation of Th1 cytokines, which would be
induced by the Il4ra p.S540fs frameshift mutation.
The Zdhhc12 p.R112C mutation (SIFT score: 0.000,
PolyPhen-2 score: 0.999) was also detected uniquely in
SAMP6 (Table 6). Zinc-finger DHHC domain-containingFigure 1 Multiple sequence alignment of periaxin. The multiple sequen
periaxin (amino acids 118–196) comprises 3 highly basic sub-domains. The
sequence KFSRLRRGLKAEAVK).protein 12, encoded by the Zdhhc12 gene, has a predicted
DHHC cysteine-rich palmitoyl acyltransferase domain
[49]. Several gene mutations in the Zdhhc family have
been implicated in human diseases and abnormal pheno-
types of mice. Remarkably, Zdhhc13-truncated mutant
mice develop alopecia, osteoporosis, and systemic amyl-
oidosis [50]; and the osteoporotic phenotype can be
explained by the finding that protein palmitoylation regu-
lates osteoblast differentiation through bone morphogen-
esis protein (BMP)-induced Osterix expression [51]. Thus
we speculate that Zdhhc12 p.R112C mutation might con-
tribute to the osteoporotic phenotype in SAMP6.
Aifm3 p.K582N mutation specific to SAMP8
Five detected deleterious mutations were unique to the
SAMP8/TaSlc strain, which show deficits in learning and
memory, emotional disorder, and abnormal circadian
rhythm at early ages (Table 7) [52,53]. It is remarkable that
the K582N mutation in the Aifm3 gene (SIFT score: 0.01,
PolyPhen-2 score: 0.879), encoding apoptosis-inducing
factor mitochondrion-associated protein 3, was detected
in SAMP8/TaSlc. Although the function of Aifm3 has not
been fully elucidated, it has been reported that Aifm3
shares 35% homology with Aifm1 and that overexpression
of Aifm3 induces apoptosis in HEK 293 cells [54]. Becausece alignment of periaxin is displayed. The nuclear localization signal of
p.R167C mutation is located in the second sub-domain (amino acid
Figure 2 Visualization of short read mapping on the Avadis NGS genome browser. (a) The Il4ra c.1860delC mutation identified in SAMP6/
TaSlc is visualized on the Avadis NGS genome browser. The reference genome sequence GRCm38 (NCBI37/mm9) is shown above, and short DNA
reads are aligned to this reference sequence. Hyphens on the reads mean nucleotide deletion at that position. (b) Sanger sequencing
chromatogram of the Il4ra gene is displayed. The Il4ra c.1860delC mutation in SAMP6/TaSlc was confirmed by Sanger sequencing.
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mammalian species, this p.K582N mutation therefore may
alter the function of Aifm3, contributing to the mitochon-
drial dysfunction in SAMP8 mice.Discussion
Whole-exome sequencing identified new candidate
mutations responsible for age-related phenotypes in
SAMP strains
In the present study, we identified the entire spectrum
of the SNVs in 6 SAMP and 3 SAMR strains by whole-
exome sequencing. We summarized the candidate muta-
tions regulating various pathogenic phenotypes in SAMP
strains in Figure 3. Our study has clarified that several
disease-causing mutations were common among mul-
tiple SAMP strains. Two of these mutations, Ogg1 p.
R304W and Mbd4 p.D129N, were common among all
SAMP strains and would be involved in the susceptibil-
ity to diseases via defects in DNA repair. In all SAMP
strains except SAMP8/TaSlc, we detected a p.R473W
missense mutation in the Ldb3 gene, which has been as-
sociated with myofibrillar myopathy. In 3 SAMP strains
(SAMP3/SlcIdr, SAMP10/TaSlc, and SAMP11/SlcIdr),
we identified a p.R167C missense mutation in the Prx
gene, which has been linked to hereditary motor and
sensory neuropathy. In 4 SAMP strains (SAMP3/SlcIdr,
SAMP6/TaSlc, SAMP10/TaSlc, and SAMP11/SlcIdr), we
detected a p.S405P missense mutation in the Gja3 gene,
which is a cause of cataract. As the candidate gene
mutations responsible for strain-specific phenotypes, we
detected 24 deleterious mutations specific to a single
SAMP strain, including the Il4ra p.S540fs frameshift
mutation in SAMP6/TaSlc, which is used as a model for
osteoporosis, and the Aifm3 p.K582N mutation inSAMP8/TaSlc mice, which display deficits in learning
and memory and mitochondrial dysfunction.
We detected Ogg1 p.R304W and Mbd4 p.D129N dele-
terious mutations, which were common to all of the
SAMP strains, but absent in the SAMR and AKR/J
strains; although these 2 mutations were also detected in
other mouse strains. It was already investigated as to
whether a defect in Ogg1 protein would affect the life
spans in SAMP strains. Mori et al. reported that hybrid
mice with the homozygous mutation in Ogg1 p.R304W
exhibited a complete loss of the glycosylase activity as
well as a higher level of 8-oxoguanine in their hepatic
nuclear DNA [23]. However, the average life span of the
SAMP1×B10.BR hybrid was not different among the
mice homozygous, heterozygous or nullzygous (B10.BL
allele) for the SAMP1 allele. Moreover, NZB/N, NFS/N,
SJL/J, and NOD/ShiLtJ also have the Ogg1 p.R304W mu-
tation. These results suggest that Ogg1 p.R304W alone is
not sufficient to cause accelerated senescence and a
short life span. We assume that the combination of
Ogg1 p.R304W and Mbd4 p.D129N causes accelerated
senescence. Both mutations were detected in the NOD/
ShiLtJ strain, which is a type 1 diabetes model [27]. Al-
though NOD/ShiLtJ mice may live for only 6 to 8
months due to diabetes under normal food and water
conditions [28], we cannot predicate these mutations to
be essential for the accelerated-senescence phenotype of
SAMP because the cause of death is different between
SAMP and NOD/ShiLtJ strains. Nevertheless, mouse
strains that possess Ogg1 p.R304W mutation are known
for their pathologic phenotypes: NZB/N for autoimmune
hemolytic anemia; SJL/J for reticulum cell sarcomas, in
addition to NOD/ShiLtJ for type 1 diabetes [55,56].
Somatic mutations have been implicated in various dis-
eases, and the accumulation of such mutations is one of
Figure 3 Summary of candidate mutations regulating various pathogenic phenotypes in SAMP strains. Described mutations except for
Ogg1 p.R304W and Mbd4 p.D129N are SAMP-specific novel non-synonymous mutations that were identified in the present study. Although Ogg1
p.R304W and Mbd4 p.D129N were detected in other strains, they would be involved in the susceptibility of diseases via defects in DNA repair.
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R304W mutation might partly contribute to the pheno-
types of these mouse strains as well as to the accelerated-
senescence phenotypes of SAMP strains.
In several SAMP strains, missense mutations were
detected in the Prx, Ldb3, and Gja3 genes, which muta-
tions have been found in various human degenerative
diseases. The pathogenesis of myofibrillar myopathy and
peripheral neurodegeneration has not been fully ana-
lyzed in SAMP strains. Age-related muscle atrophy and
a decline in peripheral neuronal function are assumed to
be a common phenomenon that probably occurs in the
course of the senescence process [57,58]. Nevertheless,
genetic susceptibility to degeneration of skeletal muscle
and peripheral neurons may be different among SAMP
strains. Prx p.R167C and Ldb3 p.R473W mutations pos-
sibly contributed to the degenerative phenotypes of 3 of
the SAMP strains in the course of the senescence
process.
In the present study, the Gja3 p.S405P mutation was
detected in 4 SAMP strains (SAMP3, SAMP6, SAMP10,
and SAMP11), among which only the SAMP3 strain is
reported to develop cataract [59]. As a lack of reports of
cataract in SAMP6, SAMP10, and SAMP11 does not in-
dicate the actual lack of cataract, careful ophthalmologic
examinations for cataracts in these 3 other SAMP strains
may reveal a pathogenic association. Alternatively, be-
cause it is suggested that the pathogenic mechanism
underlying the development of cataract in SAMP strains
is different from that of murine hereditary cataract,
which is generally regulated by single-gene mutations
[60], the Gja3 mutation alone may not be sufficient to
cause cataract. The SAMP3 strain may have additional
mutations besides the Gja3 p.S405P mutation that are
responsible for cataract.The Il4ra p.S540fs frameshift mutation can explain the
osteoporosis observed in the SAMP6 strain from the view-
point of osteo-immunology. It is known that IL-4 signaling
inhibits osteoclast differentiation by suppressing Th1 cyto-
kines such as RANKL, TNF-α, and IL-1. In fact, Il4 gene
knockout mice are sensitive to RANKL-induced bone re-
sorption [61]. A defect in Il4ra might thus enhance osteo-
clast differentiation due to dysregulation of Th1 cytokines.
The Il4ra p.S540fs frameshift mutation can also explain
the ulcerative colitis found in the SAMP6 strain. Although
the true cause of ulcerative colitis remains unknown, ab-
normalities of the immune system are possibly related to
its pathogenesis. Particularly, a high level of TNF-α was
proposed to play an important role in disease progression
[62]. In SAMP6 mice, it is expected that up-regulation of
TNF-α expression in the colon would occur due to activa-
tion of Th1 cells. Thus, both of these pathogenic pheno-
types, osteoporosis and ulcerative colitis, may be
ascribable to the defect in Il4ra in SAMP6.
We also detected the Aifm3 p.K582N mutation in the
SAMP8/TaSlc mice, which display deficits in learning and
memory. High oxidative stress derived from brain mito-
chondrial dysfunction is thought to be one of the causes
of age-related neurodegeneration in SAMP8 animals. Ac-
tually, decreased activities of NADH-cytochrome c reduc-
tase are observed even in 4-week-old SAMP8 mice,
suggesting crucial defects in maintenance of the respira-
tory chain [63]. Aifm3 is likely to be related to mitochon-
drial maintenance, because it induces apoptosis in vitro
and has an oxidoreductase domain, as is the case for
Aifm1 [54], which plays roles in maintenance of the mito-
chondrial respiratory chain [64]. However, the actual roles
of Aifm3 in apoptosis in the senescence process and the
actual substrates of the oxidoreductase remain unknown.
Further investigations are necessary to examine whether
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memory via dysfunction of brain mitochondria.
Overall, it seems that the combinations of different
disease-causing mutations specific to each strain cause
various degenerative diseases, which combinations are a
cause of short life spans of SAMP strains as far as focusing
on the mutations of the coding regions is concerned. Ac-
tually, it was reported earlier that the life spans of SAMP
strains are susceptible to environmental conditions [65].
These observations may be ascribable to the multifactorial
nature of the short life span of SAMP unlike other
progeroid mice whose life span is regulated by single gene
mutation. de Magalhaes JP et al. also reported that the
Gompertz mortality curve of the SAMP was not different
from that of the SAMR prior to age 1 year despite the dif-
ference in age when 50% of mice died, suggesting that the
life spans of the SAMP strains may not be related to aging
per se [66]. Nevertheless, we think that it is premature to
conclude that SAMP strains are degenerative disease
models rather than accelerated-senescence models be-
cause in vitro studies have shown that primary-cultured
cells from several SAMP strains show accelerated senes-
cence and higher oxidative stress and mitochondrial dys-
function than the SAMR1 strain [67-69].
Limitation of the present study
Whole-exome sequencing using 50-bp single-end reads
on the SOLiD4 platform is able to detect only single or 2-
base nucleotide variations and insertion/deletion. Because
accelerated senescence and the various pathogenic pheno-
types may not be explained completely by the nucleotide
substitutions in the coding regions, we cannot ignore the
possibility that other types of genetic variations are also in-
volved in common accelerated-senescence phenotypes of
SAMP strain. Fairfield et al. succeeded in identifying
causative mutations in several ENU-induced mutants by
exome sequencing, but failed to do so in several spontan-
eous disease models [70]. They suggested that mutations
responsible for spontaneous disease models might reside
in the non-coding regions. Actually, it has been proven
that most of the non-coding regions have some biochem-
ical functions [71].
Carter et al. reported a 15-bp insertion mutation in the
Fgf1 gene in SAMP10 [7], suggesting the involvement of a
small structural variation in an exon of this gene. A long-
read sequencing platform, which can generate over
200-bp fragments, would be required to detect them. It
has been suggested that not only small structural varia-
tions in exons, but also large genomic structural variations
such as copy number variations and gene translocations,
contribute to the complex traits of humans [72]. Further-
more, because complementary RNA probes are designed
based on reference genome sequences, we were limited to
find variants in comparison with the reference sequence.De novo assembly by whole genome sequencing or mate-
pair library sequencing and comparative genomic
hybridization (CGH) array analysis should be performed
to detect these sequence variations.
In present study, we focused on only novel deleterious
mutations that could be predicted by SIFT and PolyPhen-
2. Although these bioinformatics tools are useful to nar-
row down the candidate mutations, a recent study indi-
cated that SIFT and PolyPhen-2 show 63 and 79% correct
prediction rates, respectively [73]. In the future, functional
analyses should be conducted to confirm whether the mu-
tations that were predicted to be deleterious in the present
study really affect the functions of these genes.
Conclusions
Our study using whole-exome sequencing provides a list
of candidate mutations that are potentially linked with
various pathogenic phenotypes. As was shown in Figure 3,
2 deleterious mutations in the DNA-repair genes, i.e.,
Ogg1 p.R304W and Mbd4 p.D129N, were commonly
present among SAMP strains, which mutations would be
expected to be involved in the genetic vulnerability to age-
related diseases. Under such genetic backgrounds, dele-
terious mutations detected in each substrain may cause
various pathogenic phenotypes. We revealed that only 7
SAMP-specific non-synonymous mutations were shared
among substrains, although the mechanisms and develop-
ment of accelerated senescence and short life span have
been assumed to be the same among all of SAMP strains.
Furthermore, several SAMP strains had deleterious muta-
tions in the genes associated with hereditary diseases (e.g.,
Prx p.R167C, Ldb3 p.R473W and Gja3 p.S405P), which
mutations have not been previously reported to occur in
SAMP strains. These results suggest that comparison of
age-related phenotypes among multiple SAMP strains and
detailed histopathological reexamination are required.
Phenotypic reports of specific SAMP strains have been
biased by the researchers’ interests. The current exome se-
quence data will prompt us to scrutinize yet unnoticed
pathological features. In addition to the exome database,
construction of the comprehensive genome database of
SAMP and SAMR strains will contribute not only to a
better understanding of the fundamental aging process oc-
curring in SAM strains but also to elucidation of the
mechanisms of age-related diseases in humans as well as




Genomic DNA was extracted from the livers of 11 mouse
strains, i.e., SAMP1/SkuSlc, SAMP3/SlcIdr, SAMP6/TaSlc,
SAMP8/TaSlc, SAMP10/TaSlc, SAMP11/SlcIdr, SAMR1/
SlcIdr, SAMR1/TaSlc, SAMR3B/SlcIdr, AKR/J and
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obtain a high-quality DNA library. All experimental proce-
dures using laboratory animals were approved by
the Animal Care and Use Committee of the Tokyo Metro-
politan Institute of Gerontology, the Institute for Develop-
mental Research of the Aichi Human Service Center, and
by Shinshu University School of Medicine.
Targeted capture and next-generation sequencing
Target enrichment was performed by use of a SureSelectXT
Mouse All Exon kit (Agilent Technologies, Santa Clara,
California, US) optimized for the ABI SOLiD system and
3 μg of genomic DNA according to the manufacturer’s
protocol. The kit is designed to enrich for 221,784 exons
within 24,306 genes covering a total of 49.6 Mb genomic
sequences. DNA was sheared by acoustic fragmentation
(Covaris, Woburn, Massachusetts, US) and purified with
an Agencourt AMPure XP kit (Beckman Coulter, Brea,
California, US). The quality of the fragmentation and puri-
fication was assessed with an Agilent 2100 Bioanalyzer.
The fragment ends were repaired and adaptors were li-
gated to the fragments (Agilent). The modified DNA li-
brary was purified by using the Agencourt AMPure XP kit,
and amplified by PCR and captured by hybridization to
biotinylated RNA library baits (Agilent). Captured DNA
was purified with streptavidin-coated magnetic Dynal
beads (Life Technologies, Carlsbad, California, US) and
amplified with Barcoding Primer. The prepared exome li-
brary was pooled and subjected to emulsion PCR and se-
quenced on the SOLiD4 (Life Technologies) as single-end
50-bp reads. For each sample, 1 quad of a SOLiD sequen-
cing slide was used.
Read mapping and variant analysis
Sequence reads were mapped to the reference mouse gen-
ome (UCSC mm9, NCBI build 37) by using Bioscope soft-
ware version 1.3 (Life Technologies), which utilizes an
iterative mapping approach. After removal of low-quality
and duplicate reads, single nucleotide variants (SNVs) were
detected with Avadis NGS software version1.3 (Strand Life
Sciences, Bangalore, Karnataka, India). Avadis NGS per-
forms SNV identification via an adapted version of the
MAQ algorithm, which calculates the probability that the
consensus genotype is incorrect by using a Bayesian statis-
tical model with mapping quality, base quality and ploidy
taken into consideration. We established criteria for SNV
detection as a read coverage ≥ 2, and other parameters
were set as default values. Detected SNVs were annotated
for extracting non-synonymous and homozygous SNVs by
using the Avadis NGS with UCSC transcript annotation.
Moreover, we extracted novel SNVs by comparison with
NCBI dbSNP build 128 and SNV data of 17 inbred strains
of laboratory mice obtained by whole-genome sequencing.
We compared filtered SNVs among all strains to explorethe mutations that were commonly present among the
SAMP strains but absent in the SAMR strains, AKR/J
strain, and C57BL/6J strain. The unique mutations of each
strain were also selected.
Interpretation of novel missense SNVs
To predict whether the candidate SNVs would have dele-
terious effects or not, we used 2 software programs, i.e.,
Sorting Intolerant from Tolerant amino acid substitutions
(SIFT; J. Craig Venter Institute, San Diego, California,
US, http://sift.jcvi.org/) and Polymorphism Phenotyping
v2 (PolyPhen-2; Harvard University, Cambridge, Massachu-
setts, US, http://genetics.bwh.harvard.edu/pph2/). SIFT uses
sequence homology to predict amino acid substitutions that
will affect protein function, thus contributing to a disease
[74]. SIFT predicts substitutions with a score less than 0.05
as being “deleterious“ (Range: 0 to 1). PolyPhen-2 takes into
account the physicochemical characteristics of the wild-
type and mutated amino acid residue and the consequence
of the amino acid change for the structural properties of
the protein in addition to evolutional conservation [75].
PolyPhen-2 generates a different scale of reported scores,
with the corresponding predictions being “probably dam-
aging” with a score larger than 0.85, “possibly damaging”
with a score between 0.85 and 0.15,” and “benign” with a
score less than 0.15. Because PolyPhen-2 considers only hu-
man protein sequences, the mouse SNVs were investigated
in the context of human protein sequences.
Mutation validation
Validating the candidate SNVs was performed by using the
standard Sanger sequencing approach. Primers were
designed to surround candidate SNVs by using Primer 3
version 4.0, and custom DNA oligos were ordered (Life
Technologies; Operon Biotechnologies, Tokyo, Japan).
Primer sequences are shown in Additional file 1: Tables
S1-S2. PCR reactions were carried out in 10-μl reaction
mixtures containing a 0.5 μM concentration of each pri-
mer, 0.2 mM dNTPs, 0.25U Ex Taq DNA Polymerase Hot-
Start Version, 1.0 μl 10×Ex Taq Buffer (Takara Bio, Shiga,
Japan), and 1 μl of extracted DNA. The amplification con-
ditions were 1 cycle at 96°C for 5 min of denaturation,
40 cycles of 94°C for 30 s, 55-68°C for 45 s of annealing in
proportion to the Tm value of each primer, and extension
at 72°C for 45 s, followed by a final extension at 72°C
for 10 min. PCR products were purified by using a
MultiScreenHTS PCR 96-Well Plate (Millipore, Billerica,
Massachusetts, US) for sequences. DNA templates were
subjected to the sequencing reactions by using a BigDye
Terminator version 3.1 Cycle Sequencing Kit (Life Tech-
nologies). The sequencing reaction solution contained 4 μl
BigDye Terminator v3.1, 0.32 μM M13 forward primer,
1.75 μl 5×Sequence Buffer, and 2.0 μl PCR product in a
final volume of 10 μl. PCR conditions were 1 cycle at 94°C
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and 3 min at 60°C, followed by cleaning of the reaction
products by ethanol precipitation. The capillary electro-
phoresis sequencing was performed by using an ABI Prism
3130xl Genetic Analyzer (Life Technologies), and sequence
data were analyzed with Sequencher version 4.2.2 (Gene
Codes, Ann Arbor, Michigan, US).
Gene Ontology enrichment analysis
Gene Ontology enrichment analysis (GO analysis) was
performed by using WebGestalt (http://bioinfo.vanderbilt.
edu/webgestalt/) [76]. The obtained p-values were ad-
justed by Benjamini-Hochberg multiple testing, and the
significant level was established at p<0.05.
Multiple alignment
Multiple sequence alignment was performed by using
the Clustal Omega program on the UniProt website
(http://www.uniprot.org/) [77].
Data access
Exome data were deposited in DDBJ Sequence Read
Archive (BioProject Accession Number: PRJDB37).Additional file
Additional file 1: Table S1. Known SNV list validated by Sanger
sequencing, Table S2. Novel SNV list validated by Sanger sequencing,
Table S3. False-positive and false-negative SNV call rate, Table S4. Novel
SNVs detected among one or more of SAMP strains, but absent in the
SAMR and AKR/J strains, Table S5. List of false-positive SNVs, Table S6.
Novel deleterious mutations specific to SAMP1/SkuSlc, We identified only
Adamts5 p.A335T mutation (SIFT score: 0.00, PolyPhen-2 score: 0.810)
uniquely in SAMP1/SkuSlc. SAMP1 exhibits senile amyloidosis, impaired
immune response, contracted kidney, and lung hyperinflation [78-82]. A
disintegrin and metalloproteinase with thrombospondin motifs 5
encoded by Adamts5 gene functions as an aggrecanase to cleave
aggrecan, a major proteoglycan of cartilage [83]. Adamts5 is responsible
for aggrecan degradation in a murine model of osteoarthritis [84], and
Adamts5 knockout mice are protected against cartilage degradation
through abrogation of joint fibrosis and promoted deposition of cartilage
aggrecan [85]. The hyperinflated lungs in SAMP1 result from increased
lung compliance, which is related to age-related change in pulmonary
elasticity [80]. Although the functions of Adamts5 in tissues except
cartilage have not been fully elucidated, the expression of Adamts5 was
also observed in mouse lung. Adamts5 p.A335T mutation therefore might
play roles in hyperinflation of the lungs by affecting the pulmonary
elasticity in SAMP1. Table S7. Novel deleterious mutations specific to
SAMP3/SlcIdr, Three deleterious mutations are specific to SAMP3/SlcIdr,
which develops temporomandibular joint disease in an early stage of
development [86]. The E684K missense mutation in the Bank1 gene (SIFT
score: 0.13, PolyPhen-2 score: 0.946) encoding B-cell scaffold protein with
ankyrin repeats may be associated with temporomandibular joint disease,
because polymorphisms in this gene are associated with susceptibility to
connective tissue diseases such as rheumatoid arthritis and systemic
lupus erythematosus in humans [87,88]. Although the inflammatory
status of the temporomandibular condyle in SAMP3 was reported to be
similar to that in other SAMP strains [86], we cannot exclude the
possibility that the Bank1 p.E684K mutation contributes to the
degenerative changes in the temporomandibular joint in SAMP3. Table
S8. Novel deleterious mutations specific to SAMP10/TaSlc, We detected 4
deleterious mutations specific to SAMP10/TaSlc. Although both SAMP10and SAMP8 exhibit memory impairment, SAMP10 is distinct from SAMP8
in that cerebral atrophy occurs specifically in SAMP10 [89,90]. The Npr1 p.
M630I mutation (SIFT score; 0.03, PolyPhen-2 score; 0.939) was detected
uniquely in the SAMP10. Npr1 encodes natriuretic peptide receptor 1
(NPR-A), which is a membrane-bound guanylate cyclase that serves as
the receptor for both atrial natriuretic peptide (ANP) and brain natriuretic
peptides (BNP) [91]. The main role of ANP/BNP signaling through NPR-A
is decreasing systemic vascular resistance and blood pressure via
increasing natriuresis [92,93]. The functions of natriuretic peptides in the
nervous system also have been examined. NPR-A is mainly localized in
glial cells but not in neuronal cells in several regions of the brain [94,95].
Although the cytokine-mediated neuroprotective glial responses are
impaired in SAMP10 [96], further examination will be required to
elucidate whether the Npr1 p.M630I contributes to the degenerative
brain disorder in SAMP10. Table S9. Novel deleterious mutations specific
to SAMP11/SlcIdr, Four deleterious mutations are specific to SAMP11/
SlcIdr, which exhibits senile amyloidosis and contracted kidney, as well as
diffuse medial thickening of the aorta [3,97]. We identified the G321R
mutation in the Gja1 gene (SIFT score: 0.20, PolyPhen-2 score: 1.000)
encoding gap junction protein, alpha 1, which is a component of
intercellular channels connecting adjacent cells [98]. Gja1 is the major
protein of gap junctions in the heart [99]. The mutations in GJA1 were
proved to be the cause of several heart diseases [100,101]. Gja1 protein is
also expressed in vascular smooth muscle and is necessary for vascular
formation and maintaining vascular function [102,103]. Although the
effect of a defect of Gja1 protein on vascular morphology is not
consistent among studies, Liao et al. reported that the carotid arteries in
smooth muscle cell-specific Gja1 gene knockout mice thickens after
injury more extensively than those of wild-type mice [104], suggesting
that disruption of normal gap junctional communication contributes to
abnormal vascular phenotypes including diffuse thickening of the aorta
in SAMP11. Table S10. Top 5 overrepresented GO terms within the 31
genes including novel deleterious mutations detected among one or
more of SAMP strains, but absent in the SAMR and AKR/J strains, Table
S11. Novel deleterious mutations detected among one or more of SAMP
and SAMR strains, but absent in AKR/J strain, Table S12. Novel
deleterious mutations detected among all of the SAMPstrains and several
SAMR strains, but absent in the AKR/J strain.
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